Holly B. Lindsay, MD, MS
Department or Service
- Texas Medical Center
Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
|Baylor College of Medicine, Graduate School of Biomedical Sciences||masters||Master of Science, Clinical Investigation||2016|
|Pacific Union College||other||Bachelor of Science, Chemistry|
|Baylor College of Medicine||fellowship||Pediatric Hematology Oncology||2015|
|Washington University in St. Louis School of Medicine||medical school||Doctor of Medicine||2009|
|Children's Hospital of Los Angeles||residency||Pediatrics||2012|
|Baylor College of Medicine||fellowship||Clinical Pharmacology||2016|
Dr. Holly Lindsay’s clinical interests lie in the treatment of children with brain tumors, specifically in the treatment of Atypical Teratoid Rhabdoid Tumor and other brain tumors occurring in infants and toddlers. She is a member of the Brain Tumor Program. She has received specialized graduate level training in clinical research and pharmacology as a part of the nationally-recognized Developmental Therapeutics Program at Texas Children’s Cancer and Hematology Centers. Dr. Lindsay additionally works in the translational neuro-oncology lab of Xiao-Nan Li, MD, PhD using his animal models of childhood brain tumors to test new therapies and rapidly bring them to the clinic.
Dr. Lindsay completed her internship and residency in pediatric medicine at the Children’s Hospital of Los Angeles before relocating to Houston, TX where she completed Baylor College of Medicine’s Fellowship Program in Pediatric Hematology/Oncology at Texas Children’s Hospital, the pediatric teaching hospital of Baylor College of Medicine, and Fellowship Program in Clinical Pharmacology. She additionally earned a Masters degree in Clinical Investigation through the Baylor College of Medicine Graduate School of Biomedical Sciences’ Clinical Scientist Training Program. Her medical degree was awarded by Washington University, St. Louis School of Medicine. Prior to her medical training, she earned her Bachelor of Science in Chemistry and with an emphasis on Biochemistry and graduated Suma Cum Laude with Honors from Pacific Union College.
She is board certified by the American Board of Pediatrics and the American Board of Clinical Pharmacology.
|American Academy of Pediatrics (AAP)||Member|
|American Association for Cancer Research (AACR)||Member|
|American Society of Clinical Oncology (ASCO)||Member|
|American Society of Pediatric Hematology/Oncology (ASPHO)||Member|
|Children’s Oncology Group (COG)||Member|
|Society for Neuro-Oncology (SNO)||Member|
Dr. Holly Lindsay’s research focuses on evaluating the role of targeted therapies for the treatment of childhood brain tumors. At present, Dr. Lindsay is conducting research in the laboratory of Xiao Nan-Li, MD, PhD where she currently works with mouse models. Her work has been presented at numerous national and international meetings.